Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome

NCT01371565 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

4

Enrollment

INDUSTRY

Sponsor class

Conditions

Cushing's Disease
Cushing's Syndrome

Interventions

DRUG: Mifepristone

Sponsor

Corcept Therapeutics